This finale in the first Zelta Podcast series follows up on an article published on 8 January on Pharmaceutical-Technology.com and ClinicalTrialsArena.com, titled ‘Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses’.

The article examined the financial challenges facing clinical trials, which have created a more risk-averse landscape. It explored the digital solutions that could be key for sponsors and CROs to optimize budgets and resources, as well as the trends to watch out for in 2025.

The interviewee for that article was Jennifer Duff, Executive Vice President and General Manager of Zelta by Merative Clinical Trials Solutions. Jennifer is the guest for this episode, where we revisit the original predictions to see how accurate they were and if there were any surprises. 

Hosted on Acast. See acast.com/privacy for more information.